Drug · DIN 00035645
KEFLEX
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since August 2, 2018; first marketed December 31, 1971.
- Drug Identification Number (DIN)
- 00035645
- Company (DIN owner)
- Pendopharm Division Of Pharmascience IncMontreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Cefalexin J01DB01
- Class
- Human
- Record last updated
- June 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CEPHALEXIN | 250 MG | 5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 5, 2012: NOC 13351New Drug Submission (NDS) · Manufacturer name change
- October 5, 2009: NOC 10640New Drug Submission (NDS) · Manufacturer name change
- July 30, 2002: NOC 349New Drug Submission (NDS) · Manufacturer name change
- February 4, 2002: NOC 388New Drug Submission (NDS) · Manufacturer name change
Other DINs named KEFLEX
- DIN 00015547 · Dormant
- DIN 00244392 · Dormant
- DIN 00403628 · Dormant